These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 11036826

  • 1. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
    Nagashima M, Asano G, Yoshino S.
    J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
    Fraser A, Fearon U, Reece R, Emery P, Veale DJ.
    Arthritis Rheum; 2001 Sep; 44(9):2024-8. PubMed ID: 11592363
    [Abstract] [Full Text] [Related]

  • 3. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, Paleolog EM.
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [Abstract] [Full Text] [Related]

  • 4. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
    Kim HR, Park MK, Cho ML, Yoon CH, Lee SH, Park SH, Leng L, Bucala R, Kang I, Choe J, Kim HY.
    J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
    [Abstract] [Full Text] [Related]

  • 5. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN.
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
    [Abstract] [Full Text] [Related]

  • 15. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman MA, Kohno H, Nagasue N.
    Cancer; 2002 Nov 15; 95(10):2188-95. PubMed ID: 12412173
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta.
    Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD.
    J Rheumatol; 1997 Jul 15; 24(7):1253-9. PubMed ID: 9228120
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.